Reporting of research priorities in migraine clinical practice guidelines still need improvement—A methodological analysis
PLOS One · 30.10.2026 · 21 (10) · e0361302
DOI: 10.1371/journal.pone.0361302 ↗Kurz gefasst
Leitlinie in der Zeitschrift PLOS One, online erschienen am 30.10.2026. Verfasst von Xuejian Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China. Hauptthemen laut MEDLINE: Migraine Disorders, Practice Guidelines as Topic, Biomedical Research. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Province’s Xingdian Talents Support Program Young Scholars.
Abstract (Originalsprache)
Objectives
To systematically analyze the content and format of research priorities in clinical practice guidelines (CPGs) for migraine, providing a methodological guidance for future guideline developers and researchers.
Methods
This methodological systematic analysis involved searching six databases (Embase, PubMed CNKI, VIP, CBM and Wanfang) and the official websites of 39 authoritative organizations, including headache societies, neurology associations, and guideline development bodies. Extract information such as the name, type, and quantity of research priorities. Two reviewers independently performed data retrieval, screening, and extraction. Descriptive statistics were used to calculate the absolute frequencies and proportions of research-focused items. We have registered at INPLASY with the registration number INPLASY2025120098.
Results
Out of 96 included CPGs, 248 research priorities were identified. Only half (48, 50%) of the CPGs explicitly reported research priorities, and only 13.5% (13) included a dedicated section. The primary rationale for proposing these priorities was a lack of sufficient evidence (108, 43.5%). The nomenclature for research priorities varies widely, and structured reporting was found to be inadequate. Furthermore, 56% of priorities (139) focused on the effectiveness of interventions, primarily concerning calcitonin gene-related peptide (CGRP) monoclonal antibodies (20, 8.1%), angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) (18, 7.3%), and antiepileptic drugs (17, 6.9%).
Conclusions
The reporting of research priorities in migraine CPGs—both in content and format—requires significant improvement. Future efforts should prioritize the systematic identification and standardized reporting of research gaps in migraine and other disease areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.
- The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.
- College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Förderung
- Yunnan Province’s Xingdian Talents Support Program Young Scholars
Zitieren
APA
Yin, X., Liao, Y., Ye, Z., Zhao, Y., An, S., Tang, R., Li, Q., Yang, S., Sun, Y., Gao, Y., & Yuan, K. (2026). Reporting of research priorities in migraine clinical practice guidelines still need improvement—A methodological analysis. PLOS One, 21(10), e0361302. https://doi.org/10.1371/journal.pone.0361302
Vancouver
Yin X, Liao Y, Ye Z, Zhao Y, An S, Tang R, et al. Reporting of research priorities in migraine clinical practice guidelines still need improvement—A methodological analysis. PLOS One. 2026;21(10):e0361302. doi:10.1371/journal.pone.0361302
BibTeX
@article{Yin2026,
author = {Yin, Xuejian and Liao, Yingdi and Ye, Zhuo and Zhao, Yiyun and An, Shiyu and Tang, Riai and Li, Qinyan and Yang, Shuting and Sun, Yuze and Gao, Yicheng and Yuan, Kai},
title = {Reporting of research priorities in migraine clinical practice guidelines still need improvement—A methodological analysis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {10},
pages = {e0361302},
doi = {10.1371/journal.pone.0361302}
}
EUVIMED